Pharmacogenomics Panel & Report

Overview

Pharmacogenomics Panel

What This Test Covers

The PGx Panel evaluates gene-drug interactions that affect

Drug Metabolism Efficiency

Enzyme Activity Variations that impact drug clearance

Risk of Adverse Drug Events

Response to High-Risk Medications

Why It Matters

Who Should Take This Test

Patients prescribed multiple medications

Individuals who have experienced side effects or lack of response to medications

Patients beginning psychiatric, cardiovascular, or chronic disease medications

Healthcare Providers seeking DNA-guided precision to improve treatment outcomes

What You’ll Receive

ExtendingME Lab Analysis

Clear, Actionable PGx Report

Color-coded drug guidance by gene interaction and Medication Compatibility Overview—a quick reference for multiple drug classes.

Your Journey Begins

Clinical Insights

Summarized in a format that enhances your prescribing workflow.

Continued Education

Seamless Access

Results delivered via the ExtendingME Provider Portal.

Congenital Disease Risk Management

Turnaround Time

Results will be available approximately 2 weeks from the receipt of the sample and will be securely delivered through the Provider Portal, enabling seamless access, viewing, and sharing of reports.

Collection Method

ExtendingME kits include all necessary self-collection devices for non-invasive, at-home saliva collection, making it easy to deliver real-time, data-driven healthcare solutions without the need for lab visits.

Smarter Prescribing Starts with Genetics
Personalize medications with the Pharmacogenomics Panel. Avoid trial-and-error. Improve outcomes. Start today.

ExtendingME Testing Kit
Scroll to Top